CGI-17341 is an orally active representative of the 5-nitroimidazole series of antimicrobial agents. CGI17341 inhibits the drug-susceptible and multi-drug-resistant strains of Mycobacterium tuberculosis at concentrations ranging from 0.1 to 0.3 microgram